von Willebrand factor propeptide: biology and clinical utility

作者: Sandra L. Haberichter

DOI: 10.1182/BLOOD-2015-04-512731

关键词:

摘要: von Willebrand factor (VWF) is a large multimeric glycoprotein that mediates the attachment of platelets to damaged endothelium and also serves as carrier protein for coagulation VIII (FVIII), protecting it from proteolytic degradation. Quantitative or qualitative defects in VWF result disease (VWD), common inherited bleeding disorder. synthesized with very propeptide (VWFpp) critical intracellular processing VWF. VWFpp actively participates process multimerization essential trafficking regulated storage pathway. Mutations identified within VWD patients are associated altered structure function. The assay plasma has clinical utility assessing acute chronic vascular perturbation diseases such thrombotic thrombocytopenic purpura, sepsis, diabetes among others. clear diagnosis subtypes, particularly discriminating true type 3 subjects 1C (reduced survival VWF), which clinically important implications therapeutic treatment.

参考文章(101)
J. Voorberg, R. Fontijn, J. Calafat, H. Janssen, J.A. van Mourik, H. Pannekoek, Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. The EMBO Journal. ,vol. 12, pp. 749- 758 ,(1993) , 10.1002/J.1460-2075.1993.TB05709.X
Jef Emeis, Henk Bilo, Coen Stehouwer, Claus Thomsen, Ole Rasmussen, Kjeld Hermansen, Claes Wollheim, Jørgen Ingerslev, Ulrich Vischer, von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Thrombosis and Haemostasis. ,vol. 80, pp. 1002- 1007 ,(1998) , 10.1055/S-0037-1615401
Ulrich M Vischer, Jørgen Ingerslev, Claes B Wollheim, Jean-Claude Mestries, Dimitrios A Tsakiris, Walter E Haefeli, Egbert K O Kruithof, Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels Thrombosis and Haemostasis. ,vol. 77, pp. 387- 393 ,(1997) , 10.1055/S-0038-1655973
Simon Allen, Adel M. Abuzenadah, Joanna Hinks, Joanna L. Blagg, Turkiz Gursel, Jørgen Ingerslev, Anne C. Goodeve, Ian R. Peake, Martina E. Daly, A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion. Blood. ,vol. 96, pp. 560- 568 ,(2000) , 10.1182/BLOOD.V96.2.560
J Takagi, F Sekiya, K Kasahara, Y Inada, Y Saito, Inhibition of Platelet-Collagen Interaction by Propolypeptide of von Willebrand Factor Journal of Biological Chemistry. ,vol. 264, pp. 6017- 6020 ,(1989) , 10.1016/S0021-9258(18)83304-X
C. J. SCHOOTEN, P. TJERNBERG, E. WESTEIN, V. TERRAUBE, G. CASTAMAN, J. A. MOURIK, M. J. HOLLESTELLE, H. L. VOS, R. M. BERTINA, H. M. BERG, J. C. J. EIKENBOOM, P. J. LENTING, C. V. DENIS, Cysteine-mutations in von Willebrand factor associated with increased clearance. Journal of Thrombosis and Haemostasis. ,vol. 3, pp. 2228- 2237 ,(2005) , 10.1111/J.1538-7836.2005.01571.X
M. Erent, A. Meli, N. Moisoi, V. Babich, M. J. Hannah, P. Skehel, L. Knipe, G. Zupančič, D. Ogden, T. Carter, Rate, extent and concentration dependence of histamine-evoked Weibel-Palade body exocytosis determined from individual fusion events in human endothelial cells. The Journal of Physiology. ,vol. 583, pp. 195- 212 ,(2007) , 10.1113/JPHYSIOL.2007.132993